Lung cancer group to push Govt for funding

The UK’s first lung cancer coalition will launch next month with the aim of boosting government spending on the disease.

AstraZeneca UK, Roche and Lilly UK are among the industry members of the UK Lung Cancer Coalition (UKLCC), while Cancer Research UK, Marie Curie Cancer Care and the British Lung Foundation are also backers.

The group, the UK's largest multi-interest group in lung cancer, aims to boost funding for the disease that kills a quarter of all UK
cancer patients.

'It was felt education, services and funding were inadequate,' said Lynsey Conway, who is handling the UKLCC's media relations. She added: 'Government-led public awareness has been successful in other areas, but lung cancer treatment hasn't had a fair share.'

Launching with a 7 November event at the House of Commons, a campaign will attempt to boost the disease's profile and secure funding for research.

'With current techniques and adequate government backing, one-year survival rates can double by 2010,' said Mike Birtwistle, senior healthcare consultant at AS Biss, which is also working the UKLCC.

'Traditionally it has been a doom and gloom message for lung cancer, and we aim to turn that around.'

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in